Page last updated: 2024-11-08

biguanides and Neuroendocrine Tumors

biguanides has been researched along with Neuroendocrine Tumors in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herrera-Martínez, AD2
Pedraza-Arevalo, S1
L-López, F2
Gahete, MD2
Gálvez-Moreno, MA2
Castaño, JP2
Luque, RM2
Vázquez-Borrego, MC1
Fuentes-Fayos, AC1
Ibáñez-Costa, A1
Moreno-Moreno, P1
Alhambra-Expósito, MR1
Barrera-Martín, A1
Blanco-Acevedo, C1
Dios, E1
Venegas-Moreno, E1
Solivera, J1
Soto-Moreno, A1

Other Studies

2 other studies available for biguanides and Neuroendocrine Tumors

ArticleYear
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
    The Journal of clinical endocrinology and metabolism, 2019, 01-01, Volume: 104, Issue:1

    Topics: Adult; Aged; Apoptosis; Biguanides; Carcinoid Tumor; Cell Line, Tumor; Cell Movement; Cell Prolifera

2019
Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.
    The Journal of clinical endocrinology and metabolism, 2019, 08-01, Volume: 104, Issue:8

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Biguanides; Cell Line, Tumor; Cell

2019